ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 83 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,695,000 | -16.1% | 601,515 | 0.0% | 0.23% | +58.3% |
| Q1 2022 | $3,212,000 | -63.7% | 601,515 | 0.0% | 0.14% | -42.2% |
| Q4 2021 | $8,842,000 | -29.7% | 601,515 | 0.0% | 0.25% | -20.4% |
| Q3 2021 | $12,578,000 | +18.2% | 601,515 | 0.0% | 0.31% | +15.9% |
| Q2 2021 | $10,641,000 | -27.8% | 601,515 | 0.0% | 0.27% | -38.5% |
| Q1 2021 | $14,737,000 | -27.6% | 601,515 | 0.0% | 0.44% | -27.2% |
| Q4 2020 | $20,361,000 | +223.7% | 601,515 | +139.2% | 0.60% | +113.8% |
| Q3 2020 | $6,290,000 | -25.9% | 251,515 | 0.0% | 0.28% | -43.8% |
| Q2 2020 | $8,484,000 | – | 251,515 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $161,403,000 | 14.64% |
| Invus Financial Advisors, LLC | 1,007,575 | $34,106,000 | 14.26% |
| Euclidean Capital LLC | 1,400,435 | $47,405,000 | 10.04% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $20,387,000 | 8.63% |
| EcoR1 Capital, LLC | 3,092,218 | $104,672,000 | 5.63% |
| Ally Bridge Group (NY) LLC | 413,061 | $13,982,000 | 2.40% |
| Asymmetry Capital Management, L.P. | 67,210 | $2,275,000 | 1.04% |
| Orbimed Advisors | 2,921,967 | $98,909,000 | 0.86% |
| Casdin Capital, LLC | 601,515 | $20,361,000 | 0.60% |
| EMERALD ADVISERS, LLC | 522,302 | $17,680,000 | 0.59% |